￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Has pirtobrutinib been officially launched for use in China?

2026-02-01 22:25:32

Check Details
Detailed explanation of the latest price and purchasing channels of Lenvatinib

2026-02-01 22:25:32

Check Details
The specific reasons and relevant regulations for fezolinetant being banned in China

2026-02-01 22:25:32

Check Details
Which type of rejection reaction does belumosudil have a significant effect on and its clinical evaluation?

2026-02-01 22:25:32

Check Details
Which one is better, brivaracetam or levetiracetam, and comparative analysis

2026-02-01 22:25:32

Check Details
Authenticity and effectiveness evaluation of the Indian version of Obeticholic acid

2026-02-01 22:25:32

Check Details
What are the common side effects and adverse reactions of neratinib (neratinib) and how to deal with them

2026-02-01 22:25:32

Check Details
Has tucatinib been included in the reimbursement scope of national medical insurance?

2026-02-01 22:25:32

Check Details
Has Alpelisib been successfully included in the medical insurance directory in 2025?

2026-02-01 22:25:32

Check Details
Which class of drugs does selumetinib belong to? Is it a targeted therapy drug?

2026-02-01 22:25:32

Check Details
What is the latest launch price of cabozantinib in China in 2025?

2026-02-01 22:25:32

Check Details
Summary of standard administration methods and medication recommendations for enzalutamide

2026-02-01 22:25:32

Check Details
Category
相关知识